Aug 13, 2020
ANTI-PD-1/CTLA-4 Bi-specific Antibody (AK104) of Akeso Granted FDA Fast Track Designation for Recurrent and Metastatic Cervical Cancer
Jun 02, 2020
Innovent Announces the Preliminary Results of the Anti-CTLA-4 Monoclonal Antibody IBI310 in a Phase 1 Clinical Study
Jun 02, 2020
World Market for Next Generation Immune Checkpoint Inhibitors and Stimulators - Forecast and Opportunity Analysis
May 19, 2020
Tolero Pharmaceuticals Submits Investigational New Drug Application for Experimental PKM2 Activator TP-1454
Apr 23, 2020
Orphan Drug Act Fueling $200 Billion Dollar Market
Apr 16, 2020
Alphamab Oncology Received U.S. FDA IND Approval to Initiate A Phase II Clinical Trial of KN046 For NSCLC in the United States
Apr 15, 2020
Portage provides update on portfolio company, Intensity Therapeutics, Inc.
Feb 20, 2020
Small Cell Lung Cancer Market Size is Expected to Increase at a CAGR of 13.2% for the Study Period (2017-2030) in the 7MM | Some Market Key Players - AstraZeneca, PharmaMar, EpicentRx, United Therapeutics, Ipsen, G1 Therapeutics, Otsuka Holdings, Takeda
Feb 20, 2020
Biocare Medical Launches 7 Novel IVD Antibodies for Clinical Diagnostic and Cancer Research Applications with a Focus on Immuno-Oncology
Jan 15, 2020
John Theurer Cancer Center Participating in Early-Phase Study of Immunotherapy-Boosting Treatment
Jan 06, 2020
Global Cancer Immunotherapy Market is Forecast to hit $115 Billion by 2023 - ReportsnReports
Nov 21, 2019
Cancer Drugs and New Therapies for Dangerous Brain Tumors Advancinghl2Financialnewsmedia.com News Commentary
Oct 14, 2019
Global Cancer Immunotherapy Market is Forecast to Hit $100 Billion by 2022
Sep 21, 2019
2019 CSCO | CStone announces preliminary results from Phase I trial of CS1002 demonstrating characteristics comparable to ipilimumab
Sep 19, 2019
Partner Therapeutics Receives Orphan Drug Designation for Leukine® (sargramostim)
Sep 17, 2019
Amgen Showcases New Data From Oncology Pipeline And Portfolio At ESMO 2019
Sep 08, 2019
IASLC World Conference on Lung Cancer--Press Briefing Summary from Sunday, September 8th
Sep 05, 2019
CASI Pharmaceuticals, Inc. to Host Key Opinion Leader Symposium on September 10, 2019 in New York City
Aug 27, 2019
PIONYR Immunotherapeutics Announces Key Leadership Team Addition and Clinical Candidates Targeting Tumor-Associated Macrophages
Aug 22, 2019
CStone announces data from trials of CS1001, CS1002 and CS1003 to be released for the first time at 2019 CSCO Annual Meeting